PROMIS-25 Reliability and Validity Among Children Living with Burn Injury: A Burn Model System National Database

Alyssa M Bamer1, Kara McMullen1, Andrew Humbert1

  • 1Department of Rehabilitation Medicine, University of Washington, Seattle, Washington, USA.

Insights

The Patient Reported Outcomes Measurement System (PROMIS)-25 is reliable and valid for assessing health in pediatric burn patients. However, some domains show ceiling effects, suggesting longer PROMIS forms may be better.

Area of Science:

  • Pediatric Health Outcomes
  • Burn Injury Research
  • Psychometrics

Background:

  • Pediatric burn survivors face unique health challenges.
  • Accurate measurement of health domains is crucial for evaluating outcomes.
  • The PROMIS-25 is a widely used patient-reported outcome measure.

Purpose of the Study:

  • To evaluate the reliability and validity of the PROMIS-25 Profile v.2.0 in children with burn injuries.
  • To assess psychometric properties including internal consistency, reliability, and differential item functioning (DIF).
  • To compare findings with the general pediatric population.

Main Methods:

  • Analysis of data from 256 children (ages 8-18) with moderate to severe burn injuries.
  • Examination of floor/ceiling effects, unidimensionality, internal consistency, and reliability.
  • Concurrent validity assessed through correlations with other measures; DIF analyzed against the PROMIS pediatric general U.S. population sample.

Main Results:

  • PROMIS-25 domains demonstrated high internal consistency and unidimensionality.
  • Reliability was sufficient for group comparisons in most domains, except fatigue and anxiety.
  • Significant ceiling effects were observed in peer relationships and physical function mobility.
  • No DIF was detected concerning burn status.

Conclusions:

  • The PROMIS-25 is a reliable and valid tool for assessing health outcomes in pediatric burn patients.
  • Low to moderate reliability and ceiling effects in certain domains suggest potential benefits from longer PROMIS forms (e.g., PROMIS-37).
  • Findings support the use of PROMIS-25 in clinical research and practice for this population.